Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Capricor Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 30 | 1 | 32 | +3 |
| Shares | 2.43M | 700 | 2.62M | +191.3K (+7.9%) |
| Value | $10.3M | $3.00K | $12.5M | +$2.28M (+22.2%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Capricor Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 78,436 | $374.9K | 0.00% |
| Gsa Capital Partners LLP | 17,890 | $86.0K | 0.01% |
| Jane Street Group, LLC | 13,260 | $63.4K | 0.00% |
| Simplex Trading, LLC | 10,146 | $48.0K | 0.00% |
| Belvedere Trading LLC | 8,053 | $38.5K | 0.01% |
| Roffman Miller Associates Inc | 500 | $2.39K | 0.00% |
Sold out (3)
Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Virtu Financial LLC | 16,895 | $71.0K |
| UBS Group AG | 4,439 | $18.7K |
| Belpointe Asset Management LLC | 2,070 | $8.73K |
Not filed for Q2 2023 yet (1)
Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Householder Group Estate & Retirement Specialist, LLC | 700 | $3.00K |